Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
93.07 USD | +0.16% | +1.34% | +0.76% |
01-22 | RBC Adjusts Price Target on Gilead Sciences to $84 From $83, Maintains Sector Perform Rating | MT |
01-22 | ALX Oncology Holdings Inc. Announces Chief Financial Officer Changes | CI |
MarketScreener is also available in this country: United States.
Switch edition